Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Recombinant Coagulation Factor Concentrate Market Insights, Forecast to 2030

Global Recombinant Coagulation Factor Concentrate Market Insights, Forecast to 2030

Industry: Pharma & Healthcare

Published: 2024-11-19

Pages: 166 Pages

Report ld: 3382240

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global Recombinant Coagulation Factor Concentrate market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.

Coagulation factor is the main drug for the treatment of hemophilia, and it has experienced the evolution and development from the first generation blood-derived coagulation factor products to the second generation recombinant products and the third generation long-acting recombinant products. Recombinant coagulation factors avoid the possibility of human infection and get rid of the dependence on plasma; long-acting products improve patient compliance and treatment convenience by prolonging the half-life of drugs, and long-acting recombinant coagulation factors are the trend of future research and development.

According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines. Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.

Report Includes
This report presents an overview of global market for Recombinant Coagulation Factor Concentrate, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Recombinant Coagulation Factor Concentrate, also provides the sales of main regions and countries. of the upcoming market potential for Recombinant Coagulation Factor Concentrate, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Recombinant Coagulation Factor Concentrate sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Recombinant Coagulation Factor Concentrate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Recombinant Coagulation Factor Concentrate sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Bayer, Alprolix, Benefix, Idelvion, Lxinity, Rebinyn, Rixubis, CSL, Baxalta, Sanofi, etc.

Market Segmentation

Report Metric
Details
Report Title
Global Recombinant Coagulation Factor Concentrate Market Insights, Forecast to 2030
Global Recombinant Coagulation Factor Concentrate Companies Covered
Bayer, Alprolix, Benefix, Idelvion, Lxinity, Rebinyn, Rixubis, CSL, Baxalta, Sanofi, Biogen, Pfizer, Novo Disk, Baxter, Wyeth, Beijing Tiantan Biological Products, SHANGHAI RAAS, Taibang Biologic Group, HUALAN BIOLOGICAL ENGINEERING, Green Cross
Global Recombinant Coagulation Factor Concentrate Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Recombinant Coagulation Factor Concentrate Market, Segment by Type
250 IU

500 IU

1000 IU

2000 IU
Global Recombinant Coagulation Factor Concentrate Market, Segment by Application
Hopistial

Clinic

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Recombinant Coagulation Factor Concentrate in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Recombinant Coagulation Factor Concentrate manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Coagulation Factor Concentrate sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

Table of Contents

 1 Study Coverage
    1.1 Recombinant Coagulation Factor Concentrate Product Introduction
    1.2 Market by Type
        1.2.1 Global Recombinant Coagulation Factor Concentrate Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
        1.2.2 250 IU
        1.2.3 500 IU
        1.2.4 1000 IU
        1.2.5 2000 IU
    1.3 Market by Application
        1.3.1 Global Recombinant Coagulation Factor Concentrate Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
        1.3.2 Hopistial
        1.3.3 Clinic
        1.3.4 Others
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Executive Summary
    2.1 Global Recombinant Coagulation Factor Concentrate Revenue Estimates and Forecasts 2019-2030
    2.2 Global Recombinant Coagulation Factor Concentrate Revenue by Region
        2.2.1 Global Recombinant Coagulation Factor Concentrate Revenue by Region: 2019 VS 2023 VS 2030
        2.2.2 Global Recombinant Coagulation Factor Concentrate Revenue by Region (2019-2024)
        2.2.3 Global Recombinant Coagulation Factor Concentrate Revenue by Region (2025-2030)
        2.2.4 Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Region (2019-2030)
    2.3 Global Recombinant Coagulation Factor Concentrate Sales Estimates and Forecasts 2019-2030
    2.4 Global Recombinant Coagulation Factor Concentrate Sales by Region
        2.4.1 Global Recombinant Coagulation Factor Concentrate Sales by Region: 2019 VS 2023 VS 2030
        2.4.2 Global Recombinant Coagulation Factor Concentrate Sales by Region (2019-2024)
        2.4.3 Global Recombinant Coagulation Factor Concentrate Sales by Region (2025-2030)
        2.4.4 Global Recombinant Coagulation Factor Concentrate Sales Market Share by Region (2019-2030)
    2.5 US & Canada
    2.6 Europe
    2.7 China
    2.8 Asia (excluding China)
    2.9 Middle East, Africa and Latin America

 3 Competition by Manufacturers
    3.1 Global Recombinant Coagulation Factor Concentrate Sales by Manufacturers
        3.1.1 Global Recombinant Coagulation Factor Concentrate Sales by Manufacturers (2019-2024)
        3.1.2 Global Recombinant Coagulation Factor Concentrate Sales Market Share by Manufacturers (2019-2024)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Recombinant Coagulation Factor Concentrate in 2023
    3.2 Global Recombinant Coagulation Factor Concentrate Revenue by Manufacturers
        3.2.1 Global Recombinant Coagulation Factor Concentrate Revenue by Manufacturers (2019-2024)
        3.2.2 Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Manufacturers (2019-2024)
        3.2.3 Global Top 10 and Top 5 Companies by Recombinant Coagulation Factor Concentrate Revenue in 2023
    3.3 Global Key Players of Recombinant Coagulation Factor Concentrate, Industry Ranking, 2021 VS 2022
    3.4 Global Recombinant Coagulation Factor Concentrate Sales Price by Manufacturers (2019-2024)
    3.5 Analysis of Competitive Landscape
        3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.5.2 Global Recombinant Coagulation Factor Concentrate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.6 Global Key Manufacturers of Recombinant Coagulation Factor Concentrate, Manufacturing Base Distribution and Headquarters
    3.7 Global Key Manufacturers of Recombinant Coagulation Factor Concentrate, Product Offered and Application
    3.8 Global Key Manufacturers of Recombinant Coagulation Factor Concentrate, Date of Enter into This Industry
    3.9 Mergers & Acquisitions, Expansion Plans

 4 Market Size by Type
    4.1 Global Recombinant Coagulation Factor Concentrate Sales by Type
        4.1.1 Global Recombinant Coagulation Factor Concentrate Historical Sales by Type (2019-2024)
        4.1.2 Global Recombinant Coagulation Factor Concentrate Forecasted Sales by Type (2025-2030)
        4.1.3 Global Recombinant Coagulation Factor Concentrate Sales Market Share by Type (2019-2030)
    4.2 Global Recombinant Coagulation Factor Concentrate Revenue by Type
        4.2.1 Global Recombinant Coagulation Factor Concentrate Historical Revenue by Type (2019-2024)
        4.2.2 Global Recombinant Coagulation Factor Concentrate Forecasted Revenue by Type (2025-2030)
        4.2.3 Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Type (2019-2030)
    4.3 Global Recombinant Coagulation Factor Concentrate Price by Type
        4.3.1 Global Recombinant Coagulation Factor Concentrate Price by Type (2019-2024)
        4.3.2 Global Recombinant Coagulation Factor Concentrate Price Forecast by Type (2025-2030)

 5 Market Size by Application
    5.1 Global Recombinant Coagulation Factor Concentrate Sales by Application
        5.1.1 Global Recombinant Coagulation Factor Concentrate Historical Sales by Application (2019-2024)
        5.1.2 Global Recombinant Coagulation Factor Concentrate Forecasted Sales by Application (2025-2030)
        5.1.3 Global Recombinant Coagulation Factor Concentrate Sales Market Share by Application (2019-2030)
    5.2 Global Recombinant Coagulation Factor Concentrate Revenue by Application
        5.2.1 Global Recombinant Coagulation Factor Concentrate Historical Revenue by Application (2019-2024)
        5.2.2 Global Recombinant Coagulation Factor Concentrate Forecasted Revenue by Application (2025-2030)
        5.2.3 Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Application (2019-2030)
    5.3 Global Recombinant Coagulation Factor Concentrate Price by Application
        5.3.1 Global Recombinant Coagulation Factor Concentrate Price by Application (2019-2024)
        5.3.2 Global Recombinant Coagulation Factor Concentrate Price Forecast by Application (2025-2030)

 6 US & Canada
    6.1 US & Canada Recombinant Coagulation Factor Concentrate Market Size by Type
        6.1.1 US & Canada Recombinant Coagulation Factor Concentrate Sales by Type (2019-2030)
        6.1.2 US & Canada Recombinant Coagulation Factor Concentrate Revenue by Type (2019-2030)
    6.2 US & Canada Recombinant Coagulation Factor Concentrate Market Size by Application
        6.2.1 US & Canada Recombinant Coagulation Factor Concentrate Sales by Application (2019-2030)
        6.2.2 US & Canada Recombinant Coagulation Factor Concentrate Revenue by Application (2019-2030)
    6.3 US & Canada Recombinant Coagulation Factor Concentrate Market Size by Country
        6.3.1 US & Canada Recombinant Coagulation Factor Concentrate Revenue by Country: 2019 VS 2023 VS 2030
        6.3.2 US & Canada Recombinant Coagulation Factor Concentrate Revenue by Country (2019-2030)
        6.3.3 US & Canada Recombinant Coagulation Factor Concentrate Sales by Country (2019-2030)
        6.3.4 US
        6.3.5 Canada

 7 Europe
    7.1 Europe Recombinant Coagulation Factor Concentrate Market Size by Type
        7.1.1 Europe Recombinant Coagulation Factor Concentrate Sales by Type (2019-2030)
        7.1.2 Europe Recombinant Coagulation Factor Concentrate Revenue by Type (2019-2030)
    7.2 Europe Recombinant Coagulation Factor Concentrate Market Size by Application
        7.2.1 Europe Recombinant Coagulation Factor Concentrate Sales by Application (2019-2030)
        7.2.2 Europe Recombinant Coagulation Factor Concentrate Revenue by Application (2019-2030)
    7.3 Europe Recombinant Coagulation Factor Concentrate Market Size by Country
        7.3.1 Europe Recombinant Coagulation Factor Concentrate Revenue by Country: 2019 VS 2023 VS 2030
        7.3.2 Europe Recombinant Coagulation Factor Concentrate Revenue by Country (2019-2030)
        7.3.3 Europe Recombinant Coagulation Factor Concentrate Sales by Country (2019-2030)
        7.3.4 Germany
        7.3.5 France
        7.3.6 U.K.
        7.3.7 Italy
        7.3.8 Russia

 8 China
    8.1 China Recombinant Coagulation Factor Concentrate Market Size by Type
        8.1.1 China Recombinant Coagulation Factor Concentrate Sales by Type (2019-2030)
        8.1.2 China Recombinant Coagulation Factor Concentrate Revenue by Type (2019-2030)
    8.2 China Recombinant Coagulation Factor Concentrate Market Size by Application
        8.2.1 China Recombinant Coagulation Factor Concentrate Sales by Application (2019-2030)
        8.2.2 China Recombinant Coagulation Factor Concentrate Revenue by Application (2019-2030)

 9 Asia (excluding China)
    9.1 Asia Recombinant Coagulation Factor Concentrate Market Size by Type
        9.1.1 Asia Recombinant Coagulation Factor Concentrate Sales by Type (2019-2030)
        9.1.2 Asia Recombinant Coagulation Factor Concentrate Revenue by Type (2019-2030)
    9.2 Asia Recombinant Coagulation Factor Concentrate Market Size by Application
        9.2.1 Asia Recombinant Coagulation Factor Concentrate Sales by Application (2019-2030)
        9.2.2 Asia Recombinant Coagulation Factor Concentrate Revenue by Application (2019-2030)
    9.3 Asia Recombinant Coagulation Factor Concentrate Market Size by Region
        9.3.1 Asia Recombinant Coagulation Factor Concentrate Revenue by Region: 2019 VS 2023 VS 2030
        9.3.2 Asia Recombinant Coagulation Factor Concentrate Revenue by Region (2019-2030)
        9.3.3 Asia Recombinant Coagulation Factor Concentrate Sales by Region (2019-2030)
        9.3.4 Japan
        9.3.5 South Korea
        9.3.6 China Taiwan
        9.3.7 Southeast Asia
        9.3.8 India
        9.3.9 Australia

 10 Middle East, Africa and Latin America
    10.1 Middle East, Africa and Latin America Recombinant Coagulation Factor Concentrate Market Size by Type
        10.1.1 Middle East, Africa and Latin America Recombinant Coagulation Factor Concentrate Sales by Type (2019-2030)
        10.1.2 Middle East, Africa and Latin America Recombinant Coagulation Factor Concentrate Revenue by Type (2019-2030)
    10.2 Middle East, Africa and Latin America Recombinant Coagulation Factor Concentrate Market Size by Application
        10.2.1 Middle East, Africa and Latin America Recombinant Coagulation Factor Concentrate Sales by Application (2019-2030)
        10.2.2 Middle East, Africa and Latin America Recombinant Coagulation Factor Concentrate Revenue by Application (2019-2030)
    10.3 Middle East, Africa and Latin America Recombinant Coagulation Factor Concentrate Market Size by Country
        10.3.1 Middle East, Africa and Latin America Recombinant Coagulation Factor Concentrate Revenue by Country: 2019 VS 2023 VS 2030
        10.3.2 Middle East, Africa and Latin America Recombinant Coagulation Factor Concentrate Revenue by Country (2019-2030)
        10.3.3 Middle East, Africa and Latin America Recombinant Coagulation Factor Concentrate Sales by Country (2019-2030)
        10.3.4 Brazil
        10.3.5 Mexico
        10.3.6 Turkey
        10.3.7 Israel
        10.3.8 GCC Countries

 11 Corporate Profile
    11.1 Bayer
        11.1.1 Bayer Company Information
        11.1.2 Bayer Overview
        11.1.3 Bayer Recombinant Coagulation Factor Concentrate Sales, Price, Revenue and Gross Margin (2019-2024)
        11.1.4 Bayer Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Bayer Recent Developments
    11.2 Alprolix
        11.2.1 Alprolix Company Information
        11.2.2 Alprolix Overview
        11.2.3 Alprolix Recombinant Coagulation Factor Concentrate Sales, Price, Revenue and Gross Margin (2019-2024)
        11.2.4 Alprolix Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Alprolix Recent Developments
    11.3 Benefix
        11.3.1 Benefix Company Information
        11.3.2 Benefix Overview
        11.3.3 Benefix Recombinant Coagulation Factor Concentrate Sales, Price, Revenue and Gross Margin (2019-2024)
        11.3.4 Benefix Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Benefix Recent Developments
    11.4 Idelvion
        11.4.1 Idelvion Company Information
        11.4.2 Idelvion Overview
        11.4.3 Idelvion Recombinant Coagulation Factor Concentrate Sales, Price, Revenue and Gross Margin (2019-2024)
        11.4.4 Idelvion Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Idelvion Recent Developments
    11.5 Lxinity
        11.5.1 Lxinity Company Information
        11.5.2 Lxinity Overview
        11.5.3 Lxinity Recombinant Coagulation Factor Concentrate Sales, Price, Revenue and Gross Margin (2019-2024)
        11.5.4 Lxinity Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Lxinity Recent Developments
    11.6 Rebinyn
        11.6.1 Rebinyn Company Information
        11.6.2 Rebinyn Overview
        11.6.3 Rebinyn Recombinant Coagulation Factor Concentrate Sales, Price, Revenue and Gross Margin (2019-2024)
        11.6.4 Rebinyn Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Rebinyn Recent Developments
    11.7 Rixubis
        11.7.1 Rixubis Company Information
        11.7.2 Rixubis Overview
        11.7.3 Rixubis Recombinant Coagulation Factor Concentrate Sales, Price, Revenue and Gross Margin (2019-2024)
        11.7.4 Rixubis Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Rixubis Recent Developments
    11.8 CSL
        11.8.1 CSL Company Information
        11.8.2 CSL Overview
        11.8.3 CSL Recombinant Coagulation Factor Concentrate Sales, Price, Revenue and Gross Margin (2019-2024)
        11.8.4 CSL Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 CSL Recent Developments
    11.9 Baxalta
        11.9.1 Baxalta Company Information
        11.9.2 Baxalta Overview
        11.9.3 Baxalta Recombinant Coagulation Factor Concentrate Sales, Price, Revenue and Gross Margin (2019-2024)
        11.9.4 Baxalta Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Baxalta Recent Developments
    11.10 Sanofi
        11.10.1 Sanofi Company Information
        11.10.2 Sanofi Overview
        11.10.3 Sanofi Recombinant Coagulation Factor Concentrate Sales, Price, Revenue and Gross Margin (2019-2024)
        11.10.4 Sanofi Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Sanofi Recent Developments
    11.11 Biogen
        11.11.1 Biogen Company Information
        11.11.2 Biogen Overview
        11.11.3 Biogen Recombinant Coagulation Factor Concentrate Sales, Price, Revenue and Gross Margin (2019-2024)
        11.11.4 Biogen Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Biogen Recent Developments
    11.12 Pfizer
        11.12.1 Pfizer Company Information
        11.12.2 Pfizer Overview
        11.12.3 Pfizer Recombinant Coagulation Factor Concentrate Sales, Price, Revenue and Gross Margin (2019-2024)
        11.12.4 Pfizer Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Pfizer Recent Developments
    11.13 Novo Disk
        11.13.1 Novo Disk Company Information
        11.13.2 Novo Disk Overview
        11.13.3 Novo Disk Recombinant Coagulation Factor Concentrate Sales, Price, Revenue and Gross Margin (2019-2024)
        11.13.4 Novo Disk Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Novo Disk Recent Developments
    11.14 Baxter
        11.14.1 Baxter Company Information
        11.14.2 Baxter Overview
        11.14.3 Baxter Recombinant Coagulation Factor Concentrate Sales, Price, Revenue and Gross Margin (2019-2024)
        11.14.4 Baxter Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Baxter Recent Developments
    11.15 Wyeth
        11.15.1 Wyeth Company Information
        11.15.2 Wyeth Overview
        11.15.3 Wyeth Recombinant Coagulation Factor Concentrate Sales, Price, Revenue and Gross Margin (2019-2024)
        11.15.4 Wyeth Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
        11.15.5 Wyeth Recent Developments
    11.16 Beijing Tiantan Biological Products
        11.16.1 Beijing Tiantan Biological Products Company Information
        11.16.2 Beijing Tiantan Biological Products Overview
        11.16.3 Beijing Tiantan Biological Products Recombinant Coagulation Factor Concentrate Sales, Price, Revenue and Gross Margin (2019-2024)
        11.16.4 Beijing Tiantan Biological Products Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
        11.16.5 Beijing Tiantan Biological Products Recent Developments
    11.17 SHANGHAI RAAS
        11.17.1 SHANGHAI RAAS Company Information
        11.17.2 SHANGHAI RAAS Overview
        11.17.3 SHANGHAI RAAS Recombinant Coagulation Factor Concentrate Sales, Price, Revenue and Gross Margin (2019-2024)
        11.17.4 SHANGHAI RAAS Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
        11.17.5 SHANGHAI RAAS Recent Developments
    11.18 Taibang Biologic Group
        11.18.1 Taibang Biologic Group Company Information
        11.18.2 Taibang Biologic Group Overview
        11.18.3 Taibang Biologic Group Recombinant Coagulation Factor Concentrate Sales, Price, Revenue and Gross Margin (2019-2024)
        11.18.4 Taibang Biologic Group Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
        11.18.5 Taibang Biologic Group Recent Developments
    11.19 HUALAN BIOLOGICAL ENGINEERING
        11.19.1 HUALAN BIOLOGICAL ENGINEERING Company Information
        11.19.2 HUALAN BIOLOGICAL ENGINEERING Overview
        11.19.3 HUALAN BIOLOGICAL ENGINEERING Recombinant Coagulation Factor Concentrate Sales, Price, Revenue and Gross Margin (2019-2024)
        11.19.4 HUALAN BIOLOGICAL ENGINEERING Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
        11.19.5 HUALAN BIOLOGICAL ENGINEERING Recent Developments
    11.20 Green Cross
        11.20.1 Green Cross Company Information
        11.20.2 Green Cross Overview
        11.20.3 Green Cross Recombinant Coagulation Factor Concentrate Sales, Price, Revenue and Gross Margin (2019-2024)
        11.20.4 Green Cross Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
        11.20.5 Green Cross Recent Developments

 12 Industry Chain and Sales Channels Analysis
    12.1 Recombinant Coagulation Factor Concentrate Industry Chain Analysis
    12.2 Recombinant Coagulation Factor Concentrate Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Recombinant Coagulation Factor Concentrate Production Mode & Process
    12.4 Recombinant Coagulation Factor Concentrate Sales and Marketing
        12.4.1 Recombinant Coagulation Factor Concentrate Sales Channels
        12.4.2 Recombinant Coagulation Factor Concentrate Distributors
    12.5 Recombinant Coagulation Factor Concentrate Customers

 13 Recombinant Coagulation Factor Concentrate Market Dynamics
    13.1 Recombinant Coagulation Factor Concentrate Industry Trends
    13.2 Recombinant Coagulation Factor Concentrate Market Drivers
    13.3 Recombinant Coagulation Factor Concentrate Market Challenges
    13.4 Recombinant Coagulation Factor Concentrate Market Restraints

 14 Key Findings in the Global Recombinant Coagulation Factor Concentrate Study

 15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Author Details
    15.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Recombinant Coagulation Factor Concentrate Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Table 2. Major Manufacturers of 250 IU
 Table 3. Major Manufacturers of 500 IU
 Table 4. Major Manufacturers of 1000 IU
 Table 5. Major Manufacturers of 2000 IU
 Table 6. Global Recombinant Coagulation Factor Concentrate Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Table 7. Global Recombinant Coagulation Factor Concentrate Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 8. Global Recombinant Coagulation Factor Concentrate Revenue by Region (2019-2024) & (US$ Million)
 Table 9. Global Recombinant Coagulation Factor Concentrate Revenue by Region (2025-2030) & (US$ Million)
 Table 10. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Region (2019-2024)
 Table 11. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Region (2025-2030)
 Table 12. Global Recombinant Coagulation Factor Concentrate Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
 Table 13. Global Recombinant Coagulation Factor Concentrate Sales by Region (2019-2024) & (K Units)
 Table 14. Global Recombinant Coagulation Factor Concentrate Sales by Region (2025-2030) & (K Units)
 Table 15. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Region (2019-2024)
 Table 16. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Region (2025-2030)
 Table 17. Global Recombinant Coagulation Factor Concentrate Sales by Manufacturers (2019-2024) & (K Units)
 Table 18. Global Recombinant Coagulation Factor Concentrate Sales Share by Manufacturers (2019-2024)
 Table 19. Global Recombinant Coagulation Factor Concentrate Revenue by Manufacturers (2019-2024) & (US$ Million)
 Table 20. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Manufacturers (2019-2024)
 Table 21. Global Key Players of Recombinant Coagulation Factor Concentrate, Industry Ranking, 2021 VS 2022 VS 2023
 Table 22. Recombinant Coagulation Factor Concentrate Price by Manufacturers (2019-2024) & (US$/Unit)
 Table 23. Global Recombinant Coagulation Factor Concentrate Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 24. Global Recombinant Coagulation Factor Concentrate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Coagulation Factor Concentrate as of 2023)
 Table 25. Global Key Manufacturers of Recombinant Coagulation Factor Concentrate, Manufacturing Base Distribution and Headquarters
 Table 26. Global Key Manufacturers of Recombinant Coagulation Factor Concentrate, Product Offered and Application
 Table 27. Global Key Manufacturers of Recombinant Coagulation Factor Concentrate, Date of Enter into This Industry
 Table 28. Mergers & Acquisitions, Expansion Plans
 Table 29. Global Recombinant Coagulation Factor Concentrate Sales by Type (2019-2024) & (K Units)
 Table 30. Global Recombinant Coagulation Factor Concentrate Sales by Type (2025-2030) & (K Units)
 Table 31. Global Recombinant Coagulation Factor Concentrate Sales Share by Type (2019-2024)
 Table 32. Global Recombinant Coagulation Factor Concentrate Sales Share by Type (2025-2030)
 Table 33. Global Recombinant Coagulation Factor Concentrate Revenue by Type (2019-2024) & (US$ Million)
 Table 34. Global Recombinant Coagulation Factor Concentrate Revenue by Type (2025-2030) & (US$ Million)
 Table 35. Global Recombinant Coagulation Factor Concentrate Revenue Share by Type (2019-2024)
 Table 36. Global Recombinant Coagulation Factor Concentrate Revenue Share by Type (2025-2030)
 Table 37. Recombinant Coagulation Factor Concentrate Price by Type (2019-2024) & (US$/Unit)
 Table 38. Global Recombinant Coagulation Factor Concentrate Price Forecast by Type (2025-2030) & (US$/Unit)
 Table 39. Global Recombinant Coagulation Factor Concentrate Sales by Application (2019-2024) & (K Units)
 Table 40. Global Recombinant Coagulation Factor Concentrate Sales by Application (2025-2030) & (K Units)
 Table 41. Global Recombinant Coagulation Factor Concentrate Sales Share by Application (2019-2024)
 Table 42. Global Recombinant Coagulation Factor Concentrate Sales Share by Application (2025-2030)
 Table 43. Global Recombinant Coagulation Factor Concentrate Revenue by Application (2019-2024) & (US$ Million)
 Table 44. Global Recombinant Coagulation Factor Concentrate Revenue by Application (2025-2030) & (US$ Million)
 Table 45. Global Recombinant Coagulation Factor Concentrate Revenue Share by Application (2019-2024)
 Table 46. Global Recombinant Coagulation Factor Concentrate Revenue Share by Application (2025-2030)
 Table 47. Recombinant Coagulation Factor Concentrate Price by Application (2019-2024) & (US$/Unit)
 Table 48. Global Recombinant Coagulation Factor Concentrate Price Forecast by Application (2025-2030) & (US$/Unit)
 Table 49. US & Canada Recombinant Coagulation Factor Concentrate Sales by Type (2019-2024) & (K Units)
 Table 50. US & Canada Recombinant Coagulation Factor Concentrate Sales by Type (2025-2030) & (K Units)
 Table 51. US & Canada Recombinant Coagulation Factor Concentrate Revenue by Type (2019-2024) & (US$ Million)
 Table 52. US & Canada Recombinant Coagulation Factor Concentrate Revenue by Type (2025-2030) & (US$ Million)
 Table 53. US & Canada Recombinant Coagulation Factor Concentrate Sales by Application (2019-2024) & (K Units)
 Table 54. US & Canada Recombinant Coagulation Factor Concentrate Sales by Application (2025-2030) & (K Units)
 Table 55. US & Canada Recombinant Coagulation Factor Concentrate Revenue by Application (2019-2024) & (US$ Million)
 Table 56. US & Canada Recombinant Coagulation Factor Concentrate Revenue by Application (2025-2030) & (US$ Million)
 Table 57. US & Canada Recombinant Coagulation Factor Concentrate Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 58. US & Canada Recombinant Coagulation Factor Concentrate Revenue by Country (2019-2024) & (US$ Million)
 Table 59. US & Canada Recombinant Coagulation Factor Concentrate Revenue by Country (2025-2030) & (US$ Million)
 Table 60. US & Canada Recombinant Coagulation Factor Concentrate Sales by Country (2019-2024) & (K Units)
 Table 61. US & Canada Recombinant Coagulation Factor Concentrate Sales by Country (2025-2030) & (K Units)
 Table 62. Europe Recombinant Coagulation Factor Concentrate Sales by Type (2019-2024) & (K Units)
 Table 63. Europe Recombinant Coagulation Factor Concentrate Sales by Type (2025-2030) & (K Units)
 Table 64. Europe Recombinant Coagulation Factor Concentrate Revenue by Type (2019-2024) & (US$ Million)
 Table 65. Europe Recombinant Coagulation Factor Concentrate Revenue by Type (2025-2030) & (US$ Million)
 Table 66. Europe Recombinant Coagulation Factor Concentrate Sales by Application (2019-2024) & (K Units)
 Table 67. Europe Recombinant Coagulation Factor Concentrate Sales by Application (2025-2030) & (K Units)
 Table 68. Europe Recombinant Coagulation Factor Concentrate Revenue by Application (2019-2024) & (US$ Million)
 Table 69. Europe Recombinant Coagulation Factor Concentrate Revenue by Application (2025-2030) & (US$ Million)
 Table 70. Europe Recombinant Coagulation Factor Concentrate Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 71. Europe Recombinant Coagulation Factor Concentrate Revenue by Country (2019-2024) & (US$ Million)
 Table 72. Europe Recombinant Coagulation Factor Concentrate Revenue by Country (2025-2030) & (US$ Million)
 Table 73. Europe Recombinant Coagulation Factor Concentrate Sales by Country (2019-2024) & (K Units)
 Table 74. Europe Recombinant Coagulation Factor Concentrate Sales by Country (2025-2030) & (K Units)
 Table 75. China Recombinant Coagulation Factor Concentrate Sales by Type (2019-2024) & (K Units)
 Table 76. China Recombinant Coagulation Factor Concentrate Sales by Type (2025-2030) & (K Units)
 Table 77. China Recombinant Coagulation Factor Concentrate Revenue by Type (2019-2024) & (US$ Million)
 Table 78. China Recombinant Coagulation Factor Concentrate Revenue by Type (2025-2030) & (US$ Million)
 Table 79. China Recombinant Coagulation Factor Concentrate Sales by Application (2019-2024) & (K Units)
 Table 80. China Recombinant Coagulation Factor Concentrate Sales by Application (2025-2030) & (K Units)
 Table 81. China Recombinant Coagulation Factor Concentrate Revenue by Application (2019-2024) & (US$ Million)
 Table 82. China Recombinant Coagulation Factor Concentrate Revenue by Application (2025-2030) & (US$ Million)
 Table 83. Asia Recombinant Coagulation Factor Concentrate Sales by Type (2019-2024) & (K Units)
 Table 84. Asia Recombinant Coagulation Factor Concentrate Sales by Type (2025-2030) & (K Units)
 Table 85. Asia Recombinant Coagulation Factor Concentrate Revenue by Type (2019-2024) & (US$ Million)
 Table 86. Asia Recombinant Coagulation Factor Concentrate Revenue by Type (2025-2030) & (US$ Million)
 Table 87. Asia Recombinant Coagulation Factor Concentrate Sales by Application (2019-2024) & (K Units)
 Table 88. Asia Recombinant Coagulation Factor Concentrate Sales by Application (2025-2030) & (K Units)
 Table 89. Asia Recombinant Coagulation Factor Concentrate Revenue by Application (2019-2024) & (US$ Million)
 Table 90. Asia Recombinant Coagulation Factor Concentrate Revenue by Application (2025-2030) & (US$ Million)
 Table 91. Asia Recombinant Coagulation Factor Concentrate Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 92. Asia Recombinant Coagulation Factor Concentrate Revenue by Region (2019-2024) & (US$ Million)
 Table 93. Asia Recombinant Coagulation Factor Concentrate Revenue by Region (2025-2030) & (US$ Million)
 Table 94. Asia Recombinant Coagulation Factor Concentrate Sales by Region (2019-2024) & (K Units)
 Table 95. Asia Recombinant Coagulation Factor Concentrate Sales by Region (2025-2030) & (K Units)
 Table 96. Middle East, Africa and Latin America Recombinant Coagulation Factor Concentrate Sales by Type (2019-2024) & (K Units)
 Table 97. Middle East, Africa and Latin America Recombinant Coagulation Factor Concentrate Sales by Type (2025-2030) & (K Units)
 Table 98. Middle East, Africa and Latin America Recombinant Coagulation Factor Concentrate Revenue by Type (2019-2024) & (US$ Million)
 Table 99. Middle East, Africa and Latin America Recombinant Coagulation Factor Concentrate Revenue by Type (2025-2030) & (US$ Million)
 Table 100. Middle East, Africa and Latin America Recombinant Coagulation Factor Concentrate Sales by Application (2019-2024) & (K Units)
 Table 101. Middle East, Africa and Latin America Recombinant Coagulation Factor Concentrate Sales by Application (2025-2030) & (K Units)
 Table 102. Middle East, Africa and Latin America Recombinant Coagulation Factor Concentrate Revenue by Application (2019-2024) & (US$ Million)
 Table 103. Middle East, Africa and Latin America Recombinant Coagulation Factor Concentrate Revenue by Application (2025-2030) & (US$ Million)
 Table 104. Middle East, Africa and Latin America Recombinant Coagulation Factor Concentrate Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 105. Middle East, Africa and Latin America Recombinant Coagulation Factor Concentrate Revenue by Country (2019-2024) & (US$ Million)
 Table 106. Middle East, Africa and Latin America Recombinant Coagulation Factor Concentrate Revenue by Country (2025-2030) & (US$ Million)
 Table 107. Middle East, Africa and Latin America Recombinant Coagulation Factor Concentrate Sales by Country (2019-2024) & (K Units)
 Table 108. Middle East, Africa and Latin America Recombinant Coagulation Factor Concentrate Sales by Country (2025-2030) & (K Units)
 Table 109. Bayer Company Information
 Table 110. Bayer Description and Major Businesses
 Table 111. Bayer Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 112. Bayer Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
 Table 113. Bayer Recent Developments
 Table 114. Alprolix Company Information
 Table 115. Alprolix Description and Major Businesses
 Table 116. Alprolix Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 117. Alprolix Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
 Table 118. Alprolix Recent Developments
 Table 119. Benefix Company Information
 Table 120. Benefix Description and Major Businesses
 Table 121. Benefix Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 122. Benefix Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
 Table 123. Benefix Recent Developments
 Table 124. Idelvion Company Information
 Table 125. Idelvion Description and Major Businesses
 Table 126. Idelvion Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 127. Idelvion Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
 Table 128. Idelvion Recent Developments
 Table 129. Lxinity Company Information
 Table 130. Lxinity Description and Major Businesses
 Table 131. Lxinity Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 132. Lxinity Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
 Table 133. Lxinity Recent Developments
 Table 134. Rebinyn Company Information
 Table 135. Rebinyn Description and Major Businesses
 Table 136. Rebinyn Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 137. Rebinyn Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
 Table 138. Rebinyn Recent Developments
 Table 139. Rixubis Company Information
 Table 140. Rixubis Description and Major Businesses
 Table 141. Rixubis Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 142. Rixubis Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
 Table 143. Rixubis Recent Developments
 Table 144. CSL Company Information
 Table 145. CSL Description and Major Businesses
 Table 146. CSL Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 147. CSL Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
 Table 148. CSL Recent Developments
 Table 149. Baxalta Company Information
 Table 150. Baxalta Description and Major Businesses
 Table 151. Baxalta Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 152. Baxalta Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
 Table 153. Baxalta Recent Developments
 Table 154. Sanofi Company Information
 Table 155. Sanofi Description and Major Businesses
 Table 156. Sanofi Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 157. Sanofi Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
 Table 158. Sanofi Recent Developments
 Table 159. Biogen Company Information
 Table 160. Biogen Description and Major Businesses
 Table 161. Biogen Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 162. Biogen Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
 Table 163. Biogen Recent Developments
 Table 164. Pfizer Company Information
 Table 165. Pfizer Description and Major Businesses
 Table 166. Pfizer Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 167. Pfizer Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
 Table 168. Pfizer Recent Developments
 Table 169. Novo Disk Company Information
 Table 170. Novo Disk Description and Major Businesses
 Table 171. Novo Disk Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 172. Novo Disk Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
 Table 173. Novo Disk Recent Developments
 Table 174. Baxter Company Information
 Table 175. Baxter Description and Major Businesses
 Table 176. Baxter Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 177. Baxter Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
 Table 178. Baxter Recent Developments
 Table 179. Wyeth Company Information
 Table 180. Wyeth Description and Major Businesses
 Table 181. Wyeth Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 182. Wyeth Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
 Table 183. Wyeth Recent Developments
 Table 184. Beijing Tiantan Biological Products Company Information
 Table 185. Beijing Tiantan Biological Products Description and Major Businesses
 Table 186. Beijing Tiantan Biological Products Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 187. Beijing Tiantan Biological Products Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
 Table 188. Beijing Tiantan Biological Products Recent Developments
 Table 189. SHANGHAI RAAS Company Information
 Table 190. SHANGHAI RAAS Description and Major Businesses
 Table 191. SHANGHAI RAAS Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 192. SHANGHAI RAAS Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
 Table 193. SHANGHAI RAAS Recent Developments
 Table 194. Taibang Biologic Group Company Information
 Table 195. Taibang Biologic Group Description and Major Businesses
 Table 196. Taibang Biologic Group Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 197. Taibang Biologic Group Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
 Table 198. Taibang Biologic Group Recent Developments
 Table 199. HUALAN BIOLOGICAL ENGINEERING Company Information
 Table 200. HUALAN BIOLOGICAL ENGINEERING Description and Major Businesses
 Table 201. HUALAN BIOLOGICAL ENGINEERING Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 202. HUALAN BIOLOGICAL ENGINEERING Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
 Table 203. HUALAN BIOLOGICAL ENGINEERING Recent Developments
 Table 204. Green Cross Company Information
 Table 205. Green Cross Description and Major Businesses
 Table 206. Green Cross Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 207. Green Cross Recombinant Coagulation Factor Concentrate Product Model Numbers, Pictures, Descriptions and Specifications
 Table 208. Green Cross Recent Developments
 Table 209. Key Raw Materials Lists
 Table 210. Raw Materials Key Suppliers Lists
 Table 211. Recombinant Coagulation Factor Concentrate Distributors List
 Table 212. Recombinant Coagulation Factor Concentrate Customers List
 Table 213. Recombinant Coagulation Factor Concentrate Market Trends
 Table 214. Recombinant Coagulation Factor Concentrate Market Drivers
 Table 215. Recombinant Coagulation Factor Concentrate Market Challenges
 Table 216. Recombinant Coagulation Factor Concentrate Market Restraints
 Table 217. Research Programs/Design for This Report
 Table 218. Key Data Information from Secondary Sources
 Table 219. Key Data Information from Primary Sources


List of Figures
 Figure 1. Recombinant Coagulation Factor Concentrate Product Picture
 Figure 2. Global Recombinant Coagulation Factor Concentrate Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 3. Global Recombinant Coagulation Factor Concentrate Market Share by Type: 2023 & 2030
 Figure 4. 250 IU Product Picture
 Figure 5. 500 IU Product Picture
 Figure 6. 1000 IU Product Picture
 Figure 7. 2000 IU Product Picture
 Figure 8. Global Recombinant Coagulation Factor Concentrate Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 9. Global Recombinant Coagulation Factor Concentrate Market Share by Application: 2023 & 2030
 Figure 10. Hopistial
 Figure 11. Clinic
 Figure 12. Others
 Figure 13. Recombinant Coagulation Factor Concentrate Report Years Considered
 Figure 14. Global Recombinant Coagulation Factor Concentrate Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 15. Global Recombinant Coagulation Factor Concentrate Revenue (2019-2030) & (US$ Million)
 Figure 16. Global Recombinant Coagulation Factor Concentrate Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Figure 17. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Region in Percentage: 2023 Versus 2030
 Figure 18. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Region (2019-2030)
 Figure 19. Global Recombinant Coagulation Factor Concentrate Sales (2019-2030) & (K Units)
 Figure 20. Global Recombinant Coagulation Factor Concentrate Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
 Figure 21. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Region (2019-2030)
 Figure 22. US & Canada Recombinant Coagulation Factor Concentrate Sales YoY (2019-2030) & (K Units)
 Figure 23. US & Canada Recombinant Coagulation Factor Concentrate Revenue YoY (2019-2030) & (US$ Million)
 Figure 24. Europe Recombinant Coagulation Factor Concentrate Sales YoY (2019-2030) & (K Units)
 Figure 25. Europe Recombinant Coagulation Factor Concentrate Revenue YoY (2019-2030) & (US$ Million)
 Figure 26. China Recombinant Coagulation Factor Concentrate Sales YoY (2019-2030) & (K Units)
 Figure 27. China Recombinant Coagulation Factor Concentrate Revenue YoY (2019-2030) & (US$ Million)
 Figure 28. Asia (excluding China) Recombinant Coagulation Factor Concentrate Sales YoY (2019-2030) & (K Units)
 Figure 29. Asia (excluding China) Recombinant Coagulation Factor Concentrate Revenue YoY (2019-2030) & (US$ Million)
 Figure 30. Middle East, Africa and Latin America Recombinant Coagulation Factor Concentrate Sales YoY (2019-2030) & (K Units)
 Figure 31. Middle East, Africa and Latin America Recombinant Coagulation Factor Concentrate Revenue YoY (2019-2030) & (US$ Million)
 Figure 32. Global Recombinant Coagulation Factor Concentrate Sales Share by Manufacturers (2023)
 Figure 33. The Recombinant Coagulation Factor Concentrate Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
 Figure 34. Global Recombinant Coagulation Factor Concentrate Revenue Share by Manufacturers (2023)
 Figure 35. The Top 5 and 10 Largest Manufacturers of Recombinant Coagulation Factor Concentrate in the World: Market Share by Recombinant Coagulation Factor Concentrate Revenue in 2023
 Figure 36. Global Recombinant Coagulation Factor Concentrate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 37. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Type (2019-2030)
 Figure 38. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Type (2019-2030)
 Figure 39. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Application (2019-2030)
 Figure 40. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Application (2019-2030)
 Figure 41. US & Canada Recombinant Coagulation Factor Concentrate Sales Market Share by Type (2019-2030)
 Figure 42. US & Canada Recombinant Coagulation Factor Concentrate Revenue Market Share by Type (2019-2030)
 Figure 43. US & Canada Recombinant Coagulation Factor Concentrate Sales Market Share by Application (2019-2030)
 Figure 44. US & Canada Recombinant Coagulation Factor Concentrate Revenue Market Share by Application (2019-2030)
 Figure 45. US & Canada Recombinant Coagulation Factor Concentrate Revenue Share by Country (2019-2030)
 Figure 46. US & Canada Recombinant Coagulation Factor Concentrate Sales Share by Country (2019-2030)
 Figure 47. US Recombinant Coagulation Factor Concentrate Revenue (2019-2030) & (US$ Million)
 Figure 48. Canada Recombinant Coagulation Factor Concentrate Revenue (2019-2030) & (US$ Million)
 Figure 49. Europe Recombinant Coagulation Factor Concentrate Sales Market Share by Type (2019-2030)
 Figure 50. Europe Recombinant Coagulation Factor Concentrate Revenue Market Share by Type (2019-2030)
 Figure 51. Europe Recombinant Coagulation Factor Concentrate Sales Market Share by Application (2019-2030)
 Figure 52. Europe Recombinant Coagulation Factor Concentrate Revenue Market Share by Application (2019-2030)
 Figure 53. Europe Recombinant Coagulation Factor Concentrate Revenue Share by Country (2019-2030)
 Figure 54. Europe Recombinant Coagulation Factor Concentrate Sales Share by Country (2019-2030)
 Figure 55. Germany Recombinant Coagulation Factor Concentrate Revenue (2019-2030) & (US$ Million)
 Figure 56. France Recombinant Coagulation Factor Concentrate Revenue (2019-2030) & (US$ Million)
 Figure 57. U.K. Recombinant Coagulation Factor Concentrate Revenue (2019-2030) & (US$ Million)
 Figure 58. Italy Recombinant Coagulation Factor Concentrate Revenue (2019-2030) & (US$ Million)
 Figure 59. Russia Recombinant Coagulation Factor Concentrate Revenue (2019-2030) & (US$ Million)
 Figure 60. China Recombinant Coagulation Factor Concentrate Sales Market Share by Type (2019-2030)
 Figure 61. China Recombinant Coagulation Factor Concentrate Revenue Market Share by Type (2019-2030)
 Figure 62. China Recombinant Coagulation Factor Concentrate Sales Market Share by Application (2019-2030)
 Figure 63. China Recombinant Coagulation Factor Concentrate Revenue Market Share by Application (2019-2030)
 Figure 64. Asia Recombinant Coagulation Factor Concentrate Sales Market Share by Type (2019-2030)
 Figure 65. Asia Recombinant Coagulation Factor Concentrate Revenue Market Share by Type (2019-2030)
 Figure 66. Asia Recombinant Coagulation Factor Concentrate Sales Market Share by Application (2019-2030)
 Figure 67. Asia Recombinant Coagulation Factor Concentrate Revenue Market Share by Application (2019-2030)
 Figure 68. Asia Recombinant Coagulation Factor Concentrate Revenue Share by Region (2019-2030)
 Figure 69. Asia Recombinant Coagulation Factor Concentrate Sales Share by Region (2019-2030)
 Figure 70. Japan Recombinant Coagulation Factor Concentrate Revenue (2019-2030) & (US$ Million)
 Figure 71. South Korea Recombinant Coagulation Factor Concentrate Revenue (2019-2030) & (US$ Million)
 Figure 72. China Taiwan Recombinant Coagulation Factor Concentrate Revenue (2019-2030) & (US$ Million)
 Figure 73. Southeast Asia Recombinant Coagulation Factor Concentrate Revenue (2019-2030) & (US$ Million)
 Figure 74. India Recombinant Coagulation Factor Concentrate Revenue (2019-2030) & (US$ Million)
 Figure 75. Australia Recombinant Coagulation Factor Concentrate Revenue (2019-2030) & (US$ Million)
 Figure 76. Middle East, Africa and Latin America Recombinant Coagulation Factor Concentrate Sales Market Share by Type (2019-2030)
 Figure 77. Middle East, Africa and Latin America Recombinant Coagulation Factor Concentrate Revenue Market Share by Type (2019-2030)
 Figure 78. Middle East, Africa and Latin America Recombinant Coagulation Factor Concentrate Sales Market Share by Application (2019-2030)
 Figure 79. Middle East, Africa and Latin America Recombinant Coagulation Factor Concentrate Revenue Market Share by Application (2019-2030)
 Figure 80. Middle East, Africa and Latin America Recombinant Coagulation Factor Concentrate Revenue Share by Country (2019-2030)
 Figure 81. Middle East, Africa and Latin America Recombinant Coagulation Factor Concentrate Sales Share by Country (2019-2030)
 Figure 82. Brazil Recombinant Coagulation Factor Concentrate Revenue (2019-2030) & (US$ Million)
 Figure 83. Mexico Recombinant Coagulation Factor Concentrate Revenue (2019-2030) & (US$ Million)
 Figure 84. Turkey Recombinant Coagulation Factor Concentrate Revenue (2019-2030) & (US$ Million)
 Figure 85. Israel Recombinant Coagulation Factor Concentrate Revenue (2019-2030) & (US$ Million)
 Figure 86. GCC Countries Recombinant Coagulation Factor Concentrate Revenue (2019-2030) & (US$ Million)
 Figure 87. Recombinant Coagulation Factor Concentrate Value Chain
 Figure 88. Recombinant Coagulation Factor Concentrate Production Process
 Figure 89. Channels of Distribution (Direct Vs Distribution)
 Figure 90. Bottom-up and Top-down Approaches for This Report
 Figure 91. Data Triangulation
 Figure 92. Key Executives Interviewed

Description

The global Recombinant Coagulation Factor Concentrate market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.

Descriptive company profiles of the major global players, including Bayer, Alprolix, Benefix, Idelvion, Lxinity, Rebinyn, Rixubis, CSL, Baxalta, Sanofi, etc.

Market Segmentation